← PUMA BIOTECHNOLOGY, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $958k |
$27.7m
+2789.87%
|
$251.0m
+806.60%
|
$272.3m
+8.47%
|
$225.1m
-17.32%
|
$253.2m
+12.46%
|
$228.0m
-9.92%
|
$235.6m
+3.34%
|
$230.5m
-2.19%
|
$228.4m
-0.91%
|
$231.2m
+1.26%
|
|
| Cost of Revenue | $207k |
$5.6m
+2594.55%
|
$34.6m
+521.34%
|
$36.8m
+6.34%
|
$39.4m
+6.95%
|
$63.7m
+61.78%
|
$55.1m
-13.51%
|
$62.7m
+13.77%
|
$64.4m
+2.75%
|
$58.2m
-9.70%
|
$58.2m
+0.07%
|
|
| Cost of sales | $207k |
$5.6m
+2594.55%
|
$34.6m
+521.34%
|
$36.8m
+6.34%
|
$39.4m
+6.95%
|
$63.7m
+61.78%
|
$55.1m
-13.51%
|
$62.7m
+13.77%
|
$64.4m
+2.75%
|
$58.2m
-9.70%
|
$58.2m
+0.07%
|
|
| Gross Profit (Calculated) (derived) | $751k |
$22.1m
+2843.64%
|
$216.4m
+878.47%
|
$235.4m
+8.82%
|
$185.7m
-21.11%
|
$189.5m
+2.00%
|
$172.9m
-8.72%
|
$173.0m
+0.01%
|
$166.1m
-3.98%
|
$170.2m
+2.50%
|
— | |
| Research and Development Expense | $222.8m | $207.8m | $164.9m | $132.9m | $97.7m | $71.9m | $52.2m | $50.4m | $54.9m | $62.1m | $71.4m | |
| General and Administrative Expense | $53.8m | $106.7m | $146.2m | $141.7m | $118.5m | $116.3m | $90.0m | $89.9m | $80.2m | $70.8m | $71.4m | |
| Amortization of Intangible Assets | — | $1.6m | $3.9m | $3.9m | $6.3m | $8.0m | $8.0m | $9.7m | $9.7m | $9.7m | — | |
| Operating Lease, Expense | — | — | — | — | — | $5.1m | $4.9m | $4.9m | $4.9m | $4.5m | — | |
| Operating Expenses | $276.6m | $320.1m | $345.7m | $311.4m | $255.5m | $251.9m | $204.3m | $203.0m | $199.5m | $191.1m | $200.8m | |
| Total operating costs and expenses | $276.6m | $320.1m | $345.7m | $311.4m | $255.5m | $251.9m | $204.3m | $203.0m | $199.5m | $191.1m | — | |
| Operating Income (Loss) | ($276.6m) |
($292.4m)
-5.71%
|
($94.7m)
+67.62%
|
($39.1m)
+58.70%
|
($30.4m)
+22.24%
|
$1.3m
+104.24%
|
$23.7m
+1738.76%
|
$32.6m
+37.61%
|
$31.0m
-5.13%
|
$37.3m
+20.45%
|
$30.4m
-18.40%
|
|
| Interest income | $958k | $1.3m | $1.8m | $2.8m | $489k | $160k | $813k | $2.6m | $4.7m | $4.1m | $3.9m | |
| Other Nonoperating Income (Expense) | ($373k) | ($101k) | ($714k) | $128k | $367k | $292k | ($28k) | $759k | $862k | $1.0m | — | |
| Other income | ($373k) | ($101k) | ($714k) | $128k | $367k | $292k | ($28k) | $759k | $862k | $1.0m | — | |
| Interest Expense (non-operating) | — | $720k | $11.0m | $15.0m | $14.0m | $12.8m | $11.6m | $13.3m | $12.5m | $6.6m | $3.5m | |
| Total other expenses, net | $585k | $435k | ($18.9m) | ($36.5m) | ($29.4m) | ($30.1m) | ($23.3m) | ($10.0m) | ($6.9m) | ($1.5m) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | — | — | ($113.6m) | ($75.5m) | ($59.8m) | ($28.8m) | $457k | $22.7m | $24.1m | $35.8m | $31.2m | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | $324k | $455k | $1.1m | $897k | $1.4m | $4.5m | |
| Deferred income tax (expense) benefit | — | — | — | — | — | — | $0 | $0 | $7.1m | ($3.2m) | — | |
| Income Tax Expense (Benefit) | $0 | $0 | $17k | $53k | $207k | $324k | $455k | $1.1m | ($6.2m) | $4.7m | $4.5m | |
| Net Income (Loss) Attributable to Parent | ($276.0m) |
($292.0m)
-5.78%
|
($113.6m)
+61.10%
|
($75.6m)
+33.44%
|
($60.0m)
+20.64%
|
($29.1m)
+51.45%
|
$2k
+100.01%
|
$21.6m
+1079450.00%
|
$30.3m
+40.23%
|
$31.1m
+2.75%
|
$26.7m
-14.12%
|
|
| Earnings Per Share, Basic | — | — | — | — | — | ($29,126.00) | $0.00 | $0.46 | $0.62 | $0.62 | $0.53 | |
| Earnings Per Share, Diluted | ($8.29) | ($7.85) | ($2.99) | ($1.95) | ($1.52) | ($0.72) | $0.00 | $0.45 | $0.62 | $0.61 | $0.51 | |
| Weighted Average Number of Shares Outstanding, Basic | — | — | — | — | 39.6m | 40.6m | 44.7m | 47.1m | 48.6m | 50.0m | 50.6m | |
| Weighted-average shares of common stock outstanding—basic (in shares) | — | — | — | — | 39.6m | 40.6m | 44.7m | 47.1m | 48.6m | 50.0m | 50.6m | |
| Weighted-average shares of common stock outstanding—diluted (in shares) | — | — | — | — | 39.6m | 40.6m | 44.9m | 47.6m | 49.1m | 50.7m | 50.6m | |
| Weighted Average Number of Shares Outstanding, Diluted | — | — | — | — | 39.6m | 40.6m | 44.9m | 47.6m | 49.1m | 50.7m | 51.8m |